Literature DB >> 9819190

A quantitative HCV-PCR test for routine diagnostics.

H B Krarup1, A M Drewes, P H Madsen.   

Abstract

The aim of this study was to develop a reliable and simple method for hepatitis C virus (HCV)-PCR using standard, automated laboratory equipment. HCV-RNA was extracted from serum and amplified in a single PCR with an internal standard. The PCR product was detected using fluoroimmunoassay. Quantification was based on external and internal standards. Linearity was observed over a wide range (10-10(7) geq). Mean inter and intra serial coefficients of variation were 35% and 23%, respectively. The limit of quantification was 1000 geq/ml based on intra and inter serial variations, while levels of 110 geq/ml were always detectable. Lower concentrations were intermittently positive. The ability to separate HCV-signals in healthy and infected persons was good, based on the distribution of HCV-signals from 353 random blood donors and 191 patient samples. To illustrate the applicability of the test, HCV-RNA quantification was performed in 11 patients during treatment with interferon alpha-2b. Ten of 11 patients showed a decline in HCV-RNA within the first few weeks of treatment. After four weeks most patients were still HCV-RNA positive but below the limit of quantification. The present method for quantification of HCV-RNA was shown to have sensitivity at the level of nested PCR techniques. Until now HCV-PCR has been complicated, time-consuming and costly, and therefore not suitable for routine diagnostics. The PCR method described here is easy to perform, fast and cost-effective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819190     DOI: 10.1080/00365519850186391

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Prevalence and incidence of bloodborne viral infections among Danish prisoners.

Authors:  P B Christensen; H B Krarup; H G Niesters; H Norder; J Georgsen
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study.

Authors:  Nanna Hansen; Niels Obel; Peer B Christensen; Mette Kjær; Alex L Laursen; Henrik B Krarup; Axel Møller; Poul Schlichting; Jens Bukh; Nina Weis
Journal:  BMC Infect Dis       Date:  2011-06-21       Impact factor: 3.090

3.  Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.

Authors:  Christina Sølund; Henrik Krarup; Santseharay Ramirez; Peter Thielsen; Birgit T Røge; Suzanne Lunding; Toke S Barfod; Lone G Madsen; Britta Tarp; Peer B Christensen; Jan Gerstoft; Alex L Laursen; Jens Bukh; Nina Weis
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

4.  Influence of hepatitis C virus and IL28B genotypes on liver stiffness.

Authors:  Lene Fogt Lundbo; Louise Nygaard Clausen; Nina Weis; Kristian Schønning; Lene Rosenørn; Thomas Benfield; Peer Brehm Christensen
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

5.  Socioeconomic status in HCV infected patients - risk and prognosis.

Authors:  Lars Haukali Omland; Merete Osler; Peter Jepsen; Henrik Krarup; Nina Weis; Peer Brehm Christensen; Casper Roed; Henrik Toft Sørensen; Niels Obel
Journal:  Clin Epidemiol       Date:  2013-05-31       Impact factor: 4.790

6.  Viral load is associated with abnormal serum levels of micronutrients and glutathione and glutathione-dependent enzymes in genotype 3 HCV patients.

Authors:  Zarish Razzaq; Arif Malik
Journal:  BBA Clin       Date:  2014-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.